Author(s)

Bill E. Cham, Tania R. Chase

Vanuatu Research Centre, Port Vila, The Republic of Vanuatu;.

Atherosclerosis is the primary pathophysiological cause of heart disease and cerebrovascular disease. It is responsible for more than 20% of deaths worldwide each year. Treatments for atherosclerosis may include lifestyle changes, drugs, and medical procedures or surgery. There is a need for a rapid and effective treatment for this disease. In 1976, it was hypothesized that a multifunctional plasma delipidation process when applied to hyperlipidemic patients would lead to rapid regression of atherosclerosis. The procedure has now been applied to a variety of non-primates, primates and humans. In all models studied, large quantities of antiatherogenic lipoprotein particles were generated that led to the mechanisms of reverse cholesterol transport. Trends to regression and actual regression of atherosclerosis have now been reported using a specific plasma delipidation process consisting of lipid extraction from plasma with mixtures of butanol and ethers.

Atherosclerosis; Delipidation; Regression; Pre-β HDL; Delipidated LDL

Cham, B. and Chase, T. (2013) Intravascular infusion of autologous delipidated plasma induces antiatherogenic lipoproteins and causes regression of atherosclerosis
—Studies in non-primates, monkeys and humans. Health, 5, 19-33. doi: 10.4236/health.2013.57A1003.